Who is sponsoring NCT03849274?

NCT03849274 is sponsored by Chinese University of Hong Kong.

What drugs are being tested in NCT03849274?

Interventions in NCT03849274: Smart Scar Care Pad=Pressure Garment, Pressure Garment.

What condition does NCT03849274 study?

NCT03849274 studies Knee Arthropathy, Hip Arthropathy, Hypertrophic Scar.

Is NCT03849274 still recruiting?

NCT03849274 is currently completed. Last updated 15 March 2022.

Last reviewed 2022-03-15 · How we verify

NCT03849274

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SMART Dressing for Hypertrophic Scar Treatment Post-Total Knee/Hip Arthroplasty

Completed EARLY_PHASE1 Last updated 15 March 2022

What this trial tests

EARLY_PHASE1 trial testing Smart Scar Care Pad=Pressure Garment in Knee Arthropathy in 60 participants. Completed in 31 July 2021.

Timeline

31 January 2020

Primary endpoint
31 July 2021

31 July 2021

Quick facts

Lead sponsor	Chinese University of Hong Kong
Phase	EARLY_PHASE1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	31 January 2020
Primary completion	31 July 2021
Estimated completion	31 July 2021
Sites	1 location across Hong Kong

Drugs / interventions tested

Smart Scar Care Pad=Pressure Garment
Pressure Garment

Conditions studied

Knee Arthropathy — all drugs for Knee Arthropathy →
Hip Arthropathy — all drugs for Hip Arthropathy →
Hypertrophic Scar — all drugs for Hypertrophic Scar →

Sponsor

Chinese University of Hong Kong

Who can join

18 and older, any sex, with Knee Arthropathy or Hip Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pressure therapy (PT) and silicone therapy are recommended as first-line non-invasive treatment for Hypertrophic Scar (HS), yet the effectiveness of the combination of these two treatments through an RCT trial has not been established yet. This study aims to examine the effectiveness of the combination of adequate pressure therapy and silicone gel sheeting implemented by Smart Scar Care Pad (SSCP) + conventional Pressure Garment (PG) versus conventional Pressure Garment (PG) alone in the management of HS in adult with total hip replacement (THR) and total knee replacement (TKR). This study also aims to find out the prevalence of hypertrophic scar among patients with THR and TKR. This study is a randomised controlled trial with two parallel arms, with allocation ratio (Experimental: Control) of 1: 1 in order to establish the superiority of SSCP + PG over PG. Subjects with hypertrophic scar will be randomly assigned to either treatment or control group. The subjects in the treatment group will be provided with the SSCP and PG for treatment, whereas the subjects in the control group will be prescribed only the PG. The treatment will last for a total of 6 months. A variety of objective outcome measures will be used to analysis the treatment effect.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Knee Arthropathy

Currently open trials in the same condition.

NCT06720779 — Virtual Rehabilitation Platform for Patients With Knee Prothesis · NA · recruiting
NCT06379321 — Evaluation of Outcomes of the Triathlon Hinge Knee (THK) System · recruiting
NCT06182059 — Persistent Post Surgical Pain After Total Knee Arthroplasty · NA · recruiting
NCT06181097 — Routine Use of Negative Pressure Wound Therapy THR TKR RCT · NA · recruiting
NCT06120023 — Post-Market Clinical Follow Up for Total Knee Arthroplasty System Madison · recruiting

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03849274 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
Last refreshed: 15 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03849274.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing